NCRI - Latest Evidence For Screening In Cancer (March08)

48
Alex Mitchell Leicester Royal Infirmary Elena Baker-Glenn University of Nottingham Paul Symonds Leicester Royal Infirmary Chris Coggan Leicester General Hospital March 2008 March 2008 COMPASS – New Developments in Rapid Screening in Cancer

description

This is a briefing given to the COMPASS group http://www.compasscollaborative.com/ part of the NCRI regarding the latest methods of screening for distress in cancer.

Transcript of NCRI - Latest Evidence For Screening In Cancer (March08)

Page 1: NCRI - Latest Evidence For Screening In Cancer (March08)

Alex Mitchell Leicester Royal InfirmaryElena Baker-Glenn University of NottinghamPaul Symonds Leicester Royal InfirmaryChris Coggan Leicester General Hospital

March 2008March 2008

COMPASS – New Developments in Rapid Screening in Cancer

Page 2: NCRI - Latest Evidence For Screening In Cancer (March08)

1. What Is the Purpose of Screening?Detection Rates, Unassisted Rates, Mj Mn Subsyndromal disorders

2. Current MethodsWho is looking?; Vs case finding,

3a. Verbal MethodsEvidence?

3b. Distress ThermometerEvidence?

4. Emotion thermometersValidation

5. Future Methods

Page 3: NCRI - Latest Evidence For Screening In Cancer (March08)

MethodologyMethodology

Study I: Baker-Glen, Symonds, Granger “ET Validation”(a) n=140 chemotherapy attendees(b) n=70 chemotherapy f/u

Study II: Sampson, Symonds, Granger “ET Extension”(c) n=250 chemotherapy + late

Study III: Lord, Symonds, Granger “Coping”(d) n=250

Study IV: Mitchell, Symonds, Steward “SMI RCT”(e) n=300

Page 4: NCRI - Latest Evidence For Screening In Cancer (March08)

1. Purpose of Screening?1. Purpose of Screening?

Page 5: NCRI - Latest Evidence For Screening In Cancer (March08)
Page 6: NCRI - Latest Evidence For Screening In Cancer (March08)

Depression

13%

20%

48%

30%

38%

?%

Anxiety

Distress

Pooled Analysis of 38 studies

Setting: mostly oncology

Instruments: mixedPoint prevalence n=6414

Page 7: NCRI - Latest Evidence For Screening In Cancer (March08)
Page 8: NCRI - Latest Evidence For Screening In Cancer (March08)

Rates of Mj Mn SSRates of Mj Mn SS

11.6

8.5

31

51.1

10.3

4.7

37.2

52.2

0

10

20

30

40

50

60

Major Depression Minor Depression Subsyndromal Any Mood Problem

Baseline1 Month

Page 9: NCRI - Latest Evidence For Screening In Cancer (March08)

OutcomeOutcome0.27

0.09

0.18

0.18

0.27

Major DepressionMinor DepressionSub-SyndromalRemissionLost

Page 10: NCRI - Latest Evidence For Screening In Cancer (March08)

2. Current Detection Methods 2. Current Detection Methods

Unassisted Accuracy?

Screening Habits?

What are the optimal questions?

Page 11: NCRI - Latest Evidence For Screening In Cancer (March08)

0.00

0.10

0.20

0.30

0.40

0.50

0.60

0.70

0.80

0.90

1.00

Loss

of

ener

gy

Dim

inis

hed

driv

e

Slee

p di

stur

banc

e

Con

cent

rati

on/i

ndec

isio

n

Dep

ress

ed m

ood

Anx

iety

Dim

inis

hed

conc

entr

atio

n

Inso

mni

a

Dim

inis

hed

inte

rest

/ple

asur

e

Psyc

hic

anxi

ety

Hel

ples

snes

s

Wor

thle

ssne

ss

Hop

eles

snes

s

Som

atic

anx

iety

Tho

ught

s of

dea

th

Ang

er

Exce

ssiv

e gu

ilt

Psyc

hom

otor

cha

nge

Inde

cisi

vene

ss

Dec

reas

ed a

ppet

ite

Psyc

hom

otor

agi

tati

on

Psyc

hom

otor

ret

arda

tion

Dec

reas

ed w

eigh

t

Lack

of

reac

tive

moo

d

Incr

ease

d ap

peti

te

Hyp

erso

mni

a

Incr

ease

d w

eigh

t

All Case ProportionDepressed ProportionNon-Depressed Proportion

Mitchell, Zimmerman et al MIDAS Database. Psychol Med 2007 Submitted

N=1500

Page 12: NCRI - Latest Evidence For Screening In Cancer (March08)

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1

Depressed Mood

Diminished driveDiminished interest/pleasure

Loss of energySleep disturbance

Diminished concentration

Sensitivity

1 - Specificity

Page 13: NCRI - Latest Evidence For Screening In Cancer (March08)

3. Rapid Screening 3. Rapid Screening

Page 14: NCRI - Latest Evidence For Screening In Cancer (March08)

Test DurationTest Duration

Ultra-short screening tools were defined as those with 1-4 items taking less than 2 minutes to complete.

Short screening tools were defined as those with 5-14 items, taking between 2 and five minutes to complete.

Standard screening tools were defined as those with 15 or more items, taking more than five minutes to complete.

=> Tools table

Page 15: NCRI - Latest Evidence For Screening In Cancer (March08)

20 Instruments for Depression20 Instruments for Depression

SDS (20)Personal HQ (16)

GDS (30,15) (5)(4)(2)PHQ9 (9) (2)

DEPS (10)

Zung (20)DADS (7)

CES-D (20) (13)(10) (6)EPDS (10) (8)(6)(5)Distress Therm (1)

BSI (53)MOS-D (8)WHO-5 (5)

BDI (21) (13) (7) (2)MADRAS (10)PHQ2 (2)

HAM-D (21) (7) (6)HADS (7) (1)PHQ1

Long > 10Short > 5 < 11Ultra-short <6

Page 16: NCRI - Latest Evidence For Screening In Cancer (March08)
Page 17: NCRI - Latest Evidence For Screening In Cancer (March08)

3a. The Verbal Questions3a. The Verbal Questions

Page 18: NCRI - Latest Evidence For Screening In Cancer (March08)

1,2 or 3 Simple QQ15%

Clinical Skills Alone73%

ICD10/DSMIV0%

Short QQ3%

Other/Uncertain9% Other/Uncertain

2%

Use a QQ15%

ICD10/DSMIV13%

Clinical Skills Alone55%

1,2 or 3 Simple QQ15%

Cancer Staff Psychiatrists

Mitchell, Kaar, Poster APA 2007Current Method

Page 19: NCRI - Latest Evidence For Screening In Cancer (March08)

1,2 or 3 Simple QQ24%

Clinical Skills Alone20%

ICD10/DSMIV24%

Short QQ24%

Long QQ8%

Algorithm26%

Short QQ23%

ICD10/DSMIV0%

Clinical Skills Alone17%

1,2 or 3 Simple QQ34%

Cancer Staff Psychiatrists

Mitchell, Kaar, Poster APA 2007Ideal Method

Effective?

Page 20: NCRI - Latest Evidence For Screening In Cancer (March08)
Page 21: NCRI - Latest Evidence For Screening In Cancer (March08)

HADS-total score (n=2)

Early stage (n=3)

No diagnostic validity testing (n=39)

Simple Verbal Question Diagnostic Accuracy Studies

(n= 17)

Single depression question (n=9)

DSM Major and minor depression (n=4)

Excluded long, medium, short tests (n= 122)

Non-validated comparison (n= 1)

Insufficient data available(n= 4)

Non-cancer settings(n= 6)

Excluded primary care studies (n= 32)

Non-STARD compliant (n= 2)

Mixed stage (n=3)

Single interest question (n=3)

Two questions (n=5)

Examined Ultra-short tests (n= 98)

Verbal and Non-Verbal Studies (n=59)

Primary data reports (n= 258)

Palliative care (n=11)

Ultra-Short Method

Outcome Measure Setting / Sample

DSM Major Depression (n=11)

ICD10 Depression (n=0)

Non-verbal methods (n= 29)

Submitted BJCa

Page 22: NCRI - Latest Evidence For Screening In Cancer (March08)
Page 23: NCRI - Latest Evidence For Screening In Cancer (March08)

1.7

2.7

4.7

16.5

13.0

70.2

71.5

66.7

11.5

13.3

15.7

12.5

0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 45.0 50.0 55.0 60.0 65.0 70.0 75.0 80.0 85.0 90.0 95.0 100.0

Depression & Interest Q

Interest Question

Depression Question

False Negatives (%)Correctly Diagnosed (%)Correct Reassured (%)False Positives (%)

Depressed Non-Depressed

Depressed

Depressed

Non-Depressed

Non-Depressed

c

Real-World Performance (Prev 18%, TP TN, FP, FN)

Page 24: NCRI - Latest Evidence For Screening In Cancer (March08)

3b. The Distress Thermometer3b. The Distress Thermometer

Page 25: NCRI - Latest Evidence For Screening In Cancer (March08)

- Please circle the number (0-10) that best describes how much distress you have been experiencing in the past week, including today.

- What phone number would you like us to contact you on if necessary?

Please tick WHICH of the following is a cause of distress:

DiarrhoeaAnger

ConstipationWorry

IndigestionSadness

EatingNervousness

Is there anything important you would like to add to the list?__________________________________________________________________________________________

Mouth soresFears

BreathingDepression

Bathing/ DressingEmotional Problems

Getting around

Hot flushesSleepDealing with children

SexualFatigueDealing with partner

Feeling swollenNauseaFamily Problems

Metallic taste in mouthPain

Tingling in hands/ feetPhysical problemsWork/School

Nose dry/ congestedTransport

Skin dry/ itchyLoss of meaning or purpose in lifeMoney

FeversRelating to GodHousing

Changes in UrinationLoss of faithChildcare

Physical Problems contd…Spiritual/ Religious ConcernsPractical Problems

The distress thermometerThe distress thermometer

=> Validity

Page 26: NCRI - Latest Evidence For Screening In Cancer (March08)

Distribution of DT ScoresRansom (2006) PO (n=491)

13.814.7

15.7

13.2

10.4

8.47.7 7.3

3.7 3.3

1.8

0.0

2.0

4.0

6.0

8.0

10.0

12.0

14.0

16.0

18.0

Score 0 Score 1 Score 2 Score 3 Score 4 Score 5 Score 6 Score 7 Score 8 Score 9 Score 10

Page 27: NCRI - Latest Evidence For Screening In Cancer (March08)
Page 28: NCRI - Latest Evidence For Screening In Cancer (March08)
Page 29: NCRI - Latest Evidence For Screening In Cancer (March08)

Ultra-short Tests & DepressionUltra-short Tests & Depression

36033816787

27952643152Test -ve

18081173635Test +ve

DepressionABSENT

DepressionPRESENT

Sensitivity81%

PPV 32%

Specificity69%

NPV 93%

Prevalence 18%

N=17 studies 3603

Page 30: NCRI - Latest Evidence For Screening In Cancer (March08)

Ultra-short Tests & DistressUltra-short Tests & Distress

368222071475

18911514337Test -ve

18316931138Test +ve

DistressABSENT

DistressPRESENT

Sensitivity77%

PPV 65%

Specificity68%

NPV 80%

Prevalence 39%

N=17studies 3682

Page 31: NCRI - Latest Evidence For Screening In Cancer (March08)

Ultra-short Tests & AnxietyUltra-short Tests & Anxiety

22151372843

969776193Test -ve

1248596652Test +ve

AnxietyABSENT

AnxietyPRESENT

Sensitivity77%

PPV 55%

Specificity56%

NPV 80%

Prevalence 38%

N= 4 studies 2215

Page 32: NCRI - Latest Evidence For Screening In Cancer (March08)

Study I: Baker-Glenn et alStudy I: Baker-Glenn et al

Head-to-head comparison of

HADSPHQ2 (Q1, Q2, Q1 or Q2)PHQ9DT

Page 33: NCRI - Latest Evidence For Screening In Cancer (March08)

(3v4)

Page 34: NCRI - Latest Evidence For Screening In Cancer (March08)

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1

1 - Specificity

Sens

itivi

tyPHQ2 Two QQ

PHQ2 Interest

PHQ9

PHQ2 Depression

HADS-D DT (4v5)

DT (3v4)

HADS-T

Page 35: NCRI - Latest Evidence For Screening In Cancer (March08)

4. New Methods for 20084. New Methods for 2008

Page 36: NCRI - Latest Evidence For Screening In Cancer (March08)

See Gil F, Grassi L, Travado L, Tomamichel M, Gonzalez JR. for the SEPOS Group. Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients. Support Care Cancer, 13: 600–606, 2005

Page 37: NCRI - Latest Evidence For Screening In Cancer (March08)

0.00

0.10

0.20

0.30

0.40

0.50

0.60

0.70

0.80

0.90

1.00

DistressThermometer

AnxietyThermometer

DepressionThermometer

AngerThermometer

TenNineEightSevenSixFiveFourThreeTwoOneZero

Page 38: NCRI - Latest Evidence For Screening In Cancer (March08)

ET vs DT?ET vs DT?

Of 130 patients with predominantly early cancer, 37% scored above the cut-off recommended by the NCCN on the DT vs 69% on the ET

Of 63% DT low scorers 51% recorded emotional difficulties on the new Emotion Thermometers (ET) tool

Out of those with any emotional complication, 93.3% would be recognised using the AnxT alone, compared with 54.4% who would be recognised using the DT alone.

Page 39: NCRI - Latest Evidence For Screening In Cancer (March08)

HADS-A Score & DT Score

y = 0.9117x + 3.9311R2 = 0.4098

0

5

10

15

20

0 1 2 3 4 5 6 7 8 9 10

Page 40: NCRI - Latest Evidence For Screening In Cancer (March08)

HADS-A Score & AnxT Score

y = 1.014x + 2.3207R2 = 0.5702

0

5

10

15

20

0 1 2 3 4 5 6 7 8 9 10

Page 41: NCRI - Latest Evidence For Screening In Cancer (March08)

HADS-D Score & DT Score

y = 0.4334x + 3.3146R2 = 0.11870

5

10

15

20

0 1 2 3 4 5 6 7 8 9 10

Page 42: NCRI - Latest Evidence For Screening In Cancer (March08)

HADS-D Score & DeptT Score

y = 0.8165x + 2.7614R2 = 0.3048

0

5

10

15

20

0 1 2 3 4 5 6 7 8 9 10

Page 43: NCRI - Latest Evidence For Screening In Cancer (March08)

DT DepTVsHADS-A

AnxT AngT

AUC:DT=0.82DepT=0.84AnxT=0.87AngT=0.685

Page 44: NCRI - Latest Evidence For Screening In Cancer (March08)

DT DepTVsHADS-D

AnxT AngT

AUC:DT=0.67DepT=0.75AnxT=0.62AngT=0.69

Page 45: NCRI - Latest Evidence For Screening In Cancer (March08)

DepT & Major DepressionDepT & Major Depression

21719324

20218814Test -ve

15510Test +ve

DepressionABSENT

DepressionPRESENT

Sensitivity42%

PPV 67%

Specificity97%

NPV 93%

Prevalence 11%

DT 28%

DT79%

DT67%

DT 95%

Page 46: NCRI - Latest Evidence For Screening In Cancer (March08)

DT

15%

DT(38%)

AngT(26%)

DepT(30%)

AnxT(65%)

8%

2%

4%

0%

10%

0%

0%

0%

2%

21%

1%

2%

Page 47: NCRI - Latest Evidence For Screening In Cancer (March08)

5. Where Next? 5. Where Next?

Help

Algorithms

Page 48: NCRI - Latest Evidence For Screening In Cancer (March08)